DermTech Management
Management criteria checks 1/4
DermTech's CEO is Bret Christensen, appointed in May 2023, has a tenure of 1.17 years. total yearly compensation is $1.93M, comprised of 20.2% salary and 79.8% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth $256.23. The average tenure of the management team and the board of directors is 2.5 years and 2.8 years respectively.
Key information
Bret Christensen
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 20.2% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.007% |
| Management average tenure | 2.5yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%
May 21
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Mar 02Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%
Mar 02Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price
Dec 28Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky
Sep 18Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?
Jun 14Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023
May 10DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%
May 06We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jan 16Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)
Nov 08Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?
Oct 11DermTech grants stock options
Oct 11Diving Into DermTech
Sep 01Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80
Aug 10DermTech: Approaching An All Or Nothing Moment
Jun 13We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 04DermTech - Taking A Second Look At The Growth Thesis
Mar 31DermTech: Adoption Headwinds And Earnings Misses
Dec 23Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth
Dec 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$90m |
| Dec 31 2023 | US$2m | US$389k | -US$101m |
Compensation vs Market: Bret's total compensation ($USD1.93M) is above average for companies of similar size in the US market ($USD697.54K).
Compensation vs Earnings: Insufficient data to compare Bret's compensation with company performance.
CEO
Bret Christensen (53 yo)
1.2yrs
Tenure
US$1,928,967
Compensation
Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | US$1.93m | 0.0072% $ 256.2 | |
| CFO, Treasurer & Secretary | 4.8yrs | US$934.85k | 0.57% $ 20.4k | |
| General Counsel | 3.5yrs | US$818.76k | 0.19% $ 6.8k | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Chief Compliance Officer | 2yrs | no data | no data | |
| Chief Medical Officer | 3.1yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
2.5yrs
Average Tenure
52yo
Average Age
Experienced Management: DMTK.Q's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | US$1.93m | 0.0072% $ 256.2 | |
| Independent Director | 4.9yrs | US$149.64k | 0.28% $ 10.1k | |
| Independent Director | 2yrs | US$136.64k | 0.095% $ 3.4k | |
| Independent Chairman of the Board | 8yrs | US$188.64k | 0.35% $ 12.6k | |
| Independent Director | 2yrs | US$139.64k | 0.082% $ 2.9k | |
| Independent Director | 4.9yrs | US$156.64k | 0.20% $ 7.1k | |
| Independent Director | 2.8yrs | US$134.64k | 0.093% $ 3.3k |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Board: DMTK.Q's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.